Journal Title: Clinical & Molecular Biomedicine (CMB)

Publisher: "EDITORY-PRESS" LLC

Founder: "EDITORY-PRESS" LLC

Publisher and Editorial Office Address: Mustaqillik shoh ko‘chasi, 7-uy, Oqibat MFY, Mirzo Ulug‘bek tumani, Toshkent shahri, Uzbekistan

Publication Language: English

Year of First Publication: 2026

Publication Frequency: Quarterly (once every three months)

Specialization: Scientific, medical and biological sciences

Publication Format / Carrier: Online electronic publication

Access Model: Gold Open Access

Peer Review Model: Single-anonymized peer review

Editor-in-Chief: Prof. Imtaiyaz Hassan

Editorial Board: Full Editorial Board is available on the journal website

OAV Registration Certificate: No. 1791204

Journal Email: cmb@editorypress.uz

ISSN: Pending

Clinical & Molecular Biomedicine (CMB) is an international, peer-reviewed, open-access journal that publishes high-quality research connecting molecular discoveries with clinical applications. The journal provides a platform for scientists, clinicians, and biomedical researchers to disseminate advances in translational medicine that improve understanding, diagnosis, and treatment of human diseases.

The journal aims to promote interdisciplinary research bridging basic molecular science and clinical medicine, enabling the translation of laboratory discoveries into improved patient care. The journal focuses on translational biomedical research integrating molecular biology, clinical medicine, and emerging biomedical technologies in the following research areas:

• Translational medicine

• Molecular and cellular biology

• Clinical biochemistry

• Genomics and epigenetics

• Proteomics and metabolomics

• Microbiome research

• Molecular oncology

• Neurobiology

• Biomarker discovery

• Drug discovery and resistance

• Gene and cell therapy

• Precision medicine

• Immunology and vaccinology

The mission of CMB is to promote research that moves discoveries from bench to bedside, accelerating the development of diagnostics, therapeutics, and personalized medicine. The journal is committed to rigorous, fair, and timely peer review by experts in the field. Clinical & Molecular Biomedicine adheres to the highest standards of research ethics, data reporting, and reproducibility, ensuring that all published work is both scientifically sound and clinically meaningful.

• Rigorous peer-review process

• Open access publishing

• No article processing charge (APC)

• Rapid editorial decision

• Global editorial board

• International authorship